CHECKMATE PHARMACEUTICALS IN's ticker is CMPI and the CUSIP is 162818108. A total of 27 filers reported holding CHECKMATE PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $6,897,000 | +10.7% | 2,161,990 | -0.4% | 0.36% | +23.4% |
| Q4 2021 | $6,228,000 | -27.7% | 2,170,100 | 0.0% | 0.30% | -33.9% |
| Q3 2021 | $8,615,000 | -33.4% | 2,170,100 | 0.0% | 0.45% | -22.3% |
| Q2 2021 | $12,934,000 | -50.9% | 2,170,100 | 0.0% | 0.57% | -47.2% |
| Q1 2021 | $26,345,000 | -16.8% | 2,170,100 | 0.0% | 1.09% | -19.8% |
| Q4 2020 | $31,662,000 | +26.8% | 2,170,100 | 0.0% | 1.36% | +9.4% |
| Q3 2020 | $24,978,000 | – | 2,170,100 | – | 1.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 3,673,374 | $21,893,000 | 2.58% |
| Medicxi Ventures Management (Jersey) Ltd | 1,501,716 | $8,950,000 | 1.60% |
| Sofinnova Investments, Inc. | 3,606,707 | $21,496,000 | 1.24% |
| Omega Fund Management, LLC | 1,335,050 | $7,957,000 | 0.90% |
| Novo Holdings A/S | 2,170,100 | $12,934,000 | 0.57% |
| CLOUGH CAPITAL PARTNERS L P | 1,567,326 | $9,341,000 | 0.51% |
| SECTORAL ASSET MANAGEMENT INC | 541,766 | $3,229,000 | 0.26% |
| RBF Capital, LLC | 68,834 | $410,000 | 0.02% |
| CAMBRIDGE TRUST CO | 24,609 | $147,000 | 0.01% |
| Ergoteles LLC | 26,427 | $158,000 | 0.00% |